Bristol Myers Squibb Co SEC filings CELG-RI
Bristol Myers Squibb Co has 1,003 filings in SEC EDGAR's recent list, going back to Apr 2, 2019. Its latest annual report, Form ARS, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 8, 2026 | — |
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| FWP | Free writing prospectus | Nov 5, 2025 | — |
| 424B2 | Prospectus | Nov 3, 2025 | — |
| S-3ASR | Automatic shelf registration | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Feb 16, 2024 | — |
| FWP | Free writing prospectus | Feb 15, 2024 | — |
| 424B2 | Prospectus | Feb 13, 2024 | — |
| 424B5 | Prospectus supplement | Nov 1, 2023 | — |
| FWP | Free writing prospectus | Oct 30, 2023 | — |
| 424B3 | Prospectus | Oct 30, 2023 | — |
| 424B5 | Prospectus supplement | Feb 17, 2022 | — |
| FWP | Free writing prospectus | Feb 15, 2022 | — |
| 424B3 | Prospectus | Feb 15, 2022 | — |
| S-3ASR | Automatic shelf registration | Dec 13, 2021 | — |
| S-8 | Employee stock plan registration | May 4, 2021 | — |
| S-8 POS | Filing | May 4, 2021 | — |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
| FWP | Free writing prospectus | Nov 10, 2020 | — |
| 424B3 | Prospectus | Nov 9, 2020 | — |
| 424B3 | Prospectus | Jun 16, 2020 | — |
| S-4 | Registration for a merger or exchange | May 20, 2020 | — |
| S-8 | Employee stock plan registration | Mar 10, 2020 | — |
| S-3ASR | Automatic shelf registration | Feb 5, 2020 | — |
| S-8 | Employee stock plan registration | Nov 25, 2019 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMY (NYSE), CELG-RI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 14272
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.